Close

Baron Peter Piot

Handa Professor of Global Health

United Kingdom

Affiliations

Department of Infectious Disease Epidemiology and Dynamics
Faculty of Epidemiology and Population Health

Centres

Centre for Evaluation

Selected Publications

Emerging threat of artemisinin partial resistance markers (pfk13 mutations) in Plasmodium falciparum parasite populations in multiple geographical locations in high transmission regions of Uganda.
Agaba, BB; Travis, J; Smith, D; Rugera, SP; Zalwango, MG; Opigo, J; Katureebe, C; Mpirirwe, R; Bakary, D; ANTONIO, M; Khalid, B; Ngonzi, J; Kamya, MR; KALEEBU, P; PIOT, P; Cheng, Q;
2024
Malaria journal
Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases.
Wiedemann, A; Lhomme, E; Huchon, M; Foucat, E; Bérerd-Camara, M; Guillaumat, L; Yaradouno, M; Tambalou, J; Rodrigues, C; Ribeiro, A; Béavogui, AH; Lacabaratz, C; Thiébaut, R; Richert, L; Lévy, Y; Prevac study team,;
2024
Nature communications
From polycrisis to metacrisis: harnessing windows of opportunity for renewed political leadership in global health diplomacy.
Wong, BL H; Nordström, A; PIOT, P; Clark, H; Global Health Diplomacy Partners,;
2024
BMJ global health
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.
CHOI, EM-L; Lacarra, B; AFOLABI, MO; Ale, BM; Baiden, F; Bétard, C; Foster, J; Hamzé, B; Schwimmer, C; Manno, D; D'Ortenzio, E; Ishola, D; Keita, CM; Keshinro, B; Njie, Y; Van Dijck, W; Gaddah, A; Anumendem, D; Lowe, B; Vatrinet, R; Lawal, BJ; Otieno, GT; Samai, M; Deen, GF; Swaray, IB; ... EBOVAC-3/EBL2005 Study Team,
2023
The Lancet Global health
Randomized Trial of Vaccines for Zaire Ebola Virus Disease.
PREVAC Study Team,; Kieh, M; Richert, L; Beavogui, AH; Grund, B; Leigh, B; D'Ortenzio, E; Doumbia, S; Lhomme, E; Sow, S; Vatrinet, R; Roy, C; Kennedy, SB; Faye, S; LEES, S; Millimouno, NP; Camara, AM; Samai, M; Deen, GF; Doumbia, M; Espérou, H; Pierson, J; WATSON-JONES, D; Diallo, A; Wentworth, D; ... Yazdanpanah, Y.
2022
The New England journal of medicine
Foreword
PIOT, P;
2022
Health Dimensions of COVID-19 in India and Beyond
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa.
Barry, H; Mutua, G; Kibuuka, H; ANYWAINE, Z; Sirima, SB; Meda, N; Anzala, O; Eholie, S; Bétard, C; Richert, L; Lacabaratz, C; McElrath, MJ; De Rosa, S; Cohen, KW; Shukarev, G; Robinson, C; Gaddah, A; Heerwegh, D; Bockstal, V; Luhn, K; Leyssen, M; Douoguih, M; Thiébaut, R; EBL2002 Study group,;
2021
PLoS medicine
Future scenarios for the COVID-19 pandemic.
Skegg, D; Gluckman, P; Boulton, G; Hackmann, H; Karim, SS A; PIOT, P; Woopen, C;
2021
Lancet (London, England)
Towards Societies Living with COVID-19
PIOT, P; SPENCER, J;
2021
China CDC Weekly
See more information